Identification of potential biomarkers for idiopathic pulmonary fibrosis and validation of TDO2 as a potential therapeutic target

BACKGROUND: Idiopathic pulmonary fibrosis (IPF) is a progressive interstitial lung disease with a high mortality rate. On this basis, exploring potential therapeutic targets to meet the unmet needs of IPF patients is important. AIM: To explore novel hub genes for IPF therapy. METHODS: Here, we used...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Ru, Yang, Yan-Mei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2023
Materias:
Basic Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10308271/
https://www.ncbi.nlm.nih.gov/pubmed/37397828
http://dx.doi.org/10.4330/wjc.v15.i6.293

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10308271/
https://www.ncbi.nlm.nih.gov/pubmed/37397828
http://dx.doi.org/10.4330/wjc.v15.i6.293

Ejemplares similares